Recent advances in the treatment of chronic pain and substance use disorders.

Karlyn A Edwards, Michele J Buonora, Jessica S Merlin, Jane M Liebschutz
Author Information
  1. Karlyn A Edwards: Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, USA. Electronic address: kae132@pitt.edu.
  2. Michele J Buonora: Division of General Internal Medicine, Department of Medicine, Montefiore Medical Center & Albert Einstein College of Medicine, USA.
  3. Jessica S Merlin: Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, USA.
  4. Jane M Liebschutz: Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, USA.

Abstract

Among people with substance use disorders (SUDs), chronic pain is among the most common comorbid chronic health conditions. Chronic pain increases risk for poor SUD treatment outcomes, including risk for overdose. Given rising overdose rates across North America, a renewed research focus has emerged to better understand the contribution and treatment of chronic pain in the context of an SUD. A significant portion of this research has focused on behavioral interventions given their safety and efficacy in treating both conditions separately. Therefore, this article will describe the recent advances in the treatment of chronic pain and SUD, including promising care delivery models and behavioral treatments. Areas for further study will also be reviewed.

Keywords

References

  1. Front Psychiatry. 2023 May 12;14:1175664 [PMID: 37252141]
  2. Int J Drug Policy. 2019 Dec;74:205-215 [PMID: 31671303]
  3. Subst Abus. 2022;43(1):179-186 [PMID: 33798030]
  4. Addiction. 2021 Sep;116(9):2387-2397 [PMID: 33405304]
  5. Ann Behav Med. 2020 Oct 1;54(10):771-782 [PMID: 32227158]
  6. J Subst Abuse Treat. 2022 Dec;143:108892 [PMID: 36228338]
  7. J Pain. 2016 Jul;17(7):806-14 [PMID: 27058161]
  8. Addict Sci Clin Pract. 2024 Sep 5;19(1):64 [PMID: 39238059]
  9. Eur J Pain. 2022 Sep;26(8):1611-1635 [PMID: 35727200]
  10. Ann Behav Med. 2021 May 6;55(5):489-502 [PMID: 32914834]
  11. Subst Abus. 2016;37(1):20-4 [PMID: 26848803]
  12. J Bodyw Mov Ther. 2018 Jul;22(3):685-692 [PMID: 30100297]
  13. BMC Med. 2019 Feb 15;17(1):41 [PMID: 30770756]
  14. Pharmaceuticals (Basel). 2021 Oct 27;14(11): [PMID: 34832873]
  15. Curr Dir Psychol Sci. 2023 Jun;32(3):228-235 [PMID: 37645017]
  16. J Consult Clin Psychol. 2019 Oct;87(10):872-886 [PMID: 31556664]
  17. Pain. 2024 Mar 1;165(3):666-673 [PMID: 37733475]
  18. BMJ Open. 2024 Aug 9;14(8):e086889 [PMID: 39122392]
  19. Cannabis Cannabinoid Res. 2017 May 01;2(1):96-104 [PMID: 28861509]
  20. Disabil Health J. 2022 Jun;15(2S):101290 [PMID: 35341718]
  21. Curr Opin Psychol. 2019 Dec;30:54-58 [PMID: 30851660]
  22. Pain Med. 2020 Feb 1;21(2):e127-e138 [PMID: 31617916]
  23. Contemp Clin Trials Commun. 2021 Aug 20;23:100839 [PMID: 34485755]
  24. JAMA Netw Open. 2022 Nov 1;5(11):e2241670 [PMID: 36367731]
  25. Pain Physician. 2011 Mar-Apr;14(2):145-61 [PMID: 21412369]
  26. J Gen Intern Med. 2023 Oct;38(13):3021-3040 [PMID: 37580632]
  27. JMIR Res Protoc. 2024 Mar 20;13:e54342 [PMID: 38506917]
  28. Psychol Bull. 2010 Jul;136(4):576-600 [PMID: 20565169]
  29. Drug Alcohol Depend. 2020 Apr 1;209:107902 [PMID: 32088587]
  30. Int Rev Psychiatry. 2018 Oct;30(5):136-146 [PMID: 30398071]
  31. Neuropsychopharmacology. 2014 Jan;39(2):254-62 [PMID: 24121188]
  32. J Affect Disord. 2022 Mar 1;300:492-504 [PMID: 34986376]
  33. J Dual Diagn. 2020 Apr-Jun;16(2):239-249 [PMID: 31769729]
  34. JAMA Psychiatry. 2020 Dec 1;77(12):1225-1234 [PMID: 32725178]
  35. Pain. 2016 Jul;157(7):1373-1381 [PMID: 27023418]
  36. BMC Health Serv Res. 2024 May 3;24(1):583 [PMID: 38702685]
  37. Drug Alcohol Depend. 2024 Mar 1;256:111121 [PMID: 38367537]
  38. J Addict Med. 2019 Jan/Feb;13(1):61-68 [PMID: 30161038]
  39. J Subst Abuse Treat. 2019 Oct;105:19-27 [PMID: 31443887]
  40. J Gen Intern Med. 2020 Dec;35(Suppl 3):954-963 [PMID: 33145687]
  41. Psychiatr Clin North Am. 2003 Dec;26(4):991-1010 [PMID: 14711132]
  42. Addict Behav. 2019 May;92:173-179 [PMID: 30641335]
  43. BMC Fam Pract. 2017 Mar 20;18(1):41 [PMID: 28320337]
  44. PLoS One. 2022 Nov 28;17(11):e0271379 [PMID: 36441691]
  45. J Pain. 2020 Jul - Aug;21(7-8):798-807 [PMID: 31760109]
  46. JAMA. 2018 Jul 10;320(2):129-130 [PMID: 29896636]
  47. Subst Abuse Treat Prev Policy. 2022 May 7;17(1):35 [PMID: 35525964]
  48. Drug Alcohol Depend. 2019 Jan 1;194:460-467 [PMID: 30508769]
  49. J Pain. 2021 Apr;22(4):432-439 [PMID: 33197581]
  50. Exp Clin Psychopharmacol. 2021 Dec;29(6):593-604 [PMID: 32757595]
  51. Drug Alcohol Depend. 2015 Sep 1;154:1-13 [PMID: 26072219]
  52. Psychol Addict Behav. 2021 Feb;35(1):42-51 [PMID: 32364397]
  53. Pain. 2012 Jun;153(6):1144-1147 [PMID: 22321917]
  54. J Pain. 2021 Aug;22(8):879-891 [PMID: 33581324]
  55. Subst Use Addctn J. 2025 Jan;46(1):134-140 [PMID: 38486448]
  56. JAMA Psychiatry. 2024 Apr 1;81(4):338-346 [PMID: 38061786]
  57. Annu Rev Clin Psychol. 2019 May 7;15:503-528 [PMID: 30566371]
  58. J Pain. 2017 May;18(5):499-510 [PMID: 27919773]
  59. J Nurs Scholarsh. 2016 Jul;48(4):345-53 [PMID: 27149578]
  60. Subst Use Addctn J. 2025 Jan;46(1):146-154 [PMID: 38606900]
  61. J Telemed Telecare. 2019 Sep;25(8):484-492 [PMID: 29991316]
  62. J Pain. 2017 Dec;18(12):1459-1467 [PMID: 28760648]
  63. J Subst Abuse Treat. 2022 Jan;132:108635 [PMID: 34607731]
  64. J Psychosom Res. 1992 Dec;36(8):707-13 [PMID: 1432860]
  65. Addiction. 2024 Nov;119(11):1879-1901 [PMID: 38886901]
  66. Pain Med. 2016 Dec;17(12):2280-2290 [PMID: 28025362]
  67. J Pain. 2024 May;25(5):104439 [PMID: 38065467]

Grants

  1. K12 DA050607/NIDA NIH HHS
  2. K24 DA056837/NIDA NIH HHS

MeSH Term

Humans
Chronic Pain
Substance-Related Disorders
Behavior Therapy
Comorbidity

Word Cloud

Created with Highcharts 10.0.0paintreatmentchronicuseSUDsubstancedisordersconditionsChronicriskincludingoverdoseresearchbehavioralwilladvancesAmongpeopleSUDsamongcommoncomorbidhealthincreasespooroutcomesGivenrisingratesacrossNorthAmericarenewedfocusemergedbetterunderstandcontributioncontextsignificantportionfocusedinterventionsgivensafetyefficacytreatingseparatelyThereforearticledescriberecentpromisingcaredeliverymodelstreatmentsAreasstudyalsoreviewedRecentBehavioralPsychologicalSubstancedisorder

Similar Articles

Cited By

No available data.